Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Decision Making01:20

Decision Making

828
Decision-making is a fundamental cognitive process that involves evaluating alternatives and selecting among them. This process can range from simple choices, such as deciding what to wear, to complex decisions, like choosing a major in college or a career path. The complexity of the decision often dictates the approach we use, which can be broadly categorized into two types: automatic and controlled decision-making.
Automatic decision-making is fast, intuitive, and relies on gut feelings...
828
Decision Making: Traditional Method01:14

Decision Making: Traditional Method

5.0K
The process of hypothesis testing based on the traditional method includes calculating the critical value, testing the value of the test statistic using the sample data, and interpreting these values.
First, a specific claim about the population parameter is decided based on the research question and is stated in a simple form. Further, an opposing statement to this claim is also stated. These statements can act as null and alternative hypotheses, out of which a null hypothesis would be a...
5.0K
Decision Making: P-value Method01:09

Decision Making: P-value Method

6.8K
The process of hypothesis testing based on the P-value method includes calculating the P- value using the sample data and interpreting it.
First, a specific claim about the population parameter is proposed. The claim is based on the research question and is stated in a simple form. Further, an opposing statement to the claim  is also stated. These statements can act as null and alternative hypotheses:  a null hypothesis would be a neutral statement while the alternative hypothesis can...
6.8K
Heuristics01:21

Heuristics

590
Heuristics are problem-solving strategies that use mental shortcuts to simplify decision-making. Unlike algorithms, which must be followed precisely to achieve a correct result, heuristics offer a general problem-solving framework. They save time and energy but can sometimes lead to less rational decisions.
People often rely on heuristics when faced with an overload of information, limited time, low importance of the decision, limited information, or when a heuristic readily comes to mind. For...
590
Case Studies01:22

Case Studies

13.2K
There are many research methods available to psychologists in their efforts to understand, describe, and explain behavior and the cognitive and biological processes that underlie it.
13.2K
Design Example: Analyzing Capacity Contours for Flood Risk Assessment01:17

Design Example: Analyzing Capacity Contours for Flood Risk Assessment

252
Flood risk assessment involves careful planning and analysis to ensure the safety of communities near water retention structures. Capacity contours are a vital tool in this process, as they illustrate the potential spread of water at specific levels in a given area. In the context of building a bund across a small valley, these contours play a critical role in evaluating the safety of nearby residential areas.In this example, the bund is intended to store stormwater in the valley. The engineers...
252

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Challenging the myths of subcutaneous delivery: An industry expert perspective.

Journal of controlled release : official journal of the Controlled Release Society·2026
Same author

Removal notice to 'Challenging the myths of subcutaneous delivery: An industry expert perspective' [Journal of Controlled Release 393 (2026) 114800].

Journal of controlled release : official journal of the Controlled Release Society·2026
Same author

Challenging the myths of subcutaneous delivery: An industry expert perspective.

Journal of controlled release : official journal of the Controlled Release Society·2026
Same author

TPP-45142-an Anti-HER2 T-cell Engager-Designed for Selective HER2-Low Cancer Immunotherapy.

Molecular cancer therapeutics·2026
Same author

Biallelic antigen escape is a mechanism of resistance to anti-CD38 antibodies in multiple myeloma.

Blood·2025
Same author

Structural Biology for Target Identification and Validation.

Methods in molecular biology (Clifton, N.J.)·2025
Same journal

[CREPT: An ally of immunotherapy for the fight against non-small-cell lung cancers].

Medecine sciences : M/S·2026
Same journal

[A new regulatory mechanism of HIF-1α: the ROS-ATM-CHK2 axis at the core of tumor angiogenesis].

Medecine sciences : M/S·2026
Same journal

[Vibrio-host interactions: from the environmental niche to virulence].

Medecine sciences : M/S·2026
Same journal

[RcsF, hyperconnected sentinel of the bacterial envelope].

Medecine sciences : M/S·2026
Same journal

[Single-cell RNA-sequencing: shattering the clone myth].

Medecine sciences : M/S·2026
Same journal

[No, Physarum blobs do not have 720 sexes!]

Medecine sciences : M/S·2026
See all related articles

Related Experiment Video

Updated: Dec 31, 2025

Operant Protocols for Assessing the Cost-benefit Analysis During Reinforced Decision Making by Rodents
07:05

Operant Protocols for Assessing the Cost-benefit Analysis During Reinforced Decision Making by Rodents

Published on: September 10, 2018

6.4K

[Developability assessment with case studies highlighting the decision taking].

Jacques Dumas1, Anne Sévérac1, Cendrine Lemoine1

  • 1Biologics Research/Sanofi R&D, 13 quai Jules Guesde, 94403 Vitry-sur-Seine, France.

Medecine Sciences : M/S
|January 7, 2020
PubMed
Summary
This summary is machine-generated.

Generating therapeutic antibodies needs to be faster and cheaper. Combining in silico predictions with advanced screening and characterization technologies is essential for efficient antibody development.

More Related Videos

Practical Methodology of Cognitive Tasks Within a Navigational Assessment
05:19

Practical Methodology of Cognitive Tasks Within a Navigational Assessment

Published on: June 1, 2015

14.0K
Assessing Dyslexia at Six Year of Age
15:00

Assessing Dyslexia at Six Year of Age

Published on: May 1, 2020

8.7K

Related Experiment Videos

Last Updated: Dec 31, 2025

Operant Protocols for Assessing the Cost-benefit Analysis During Reinforced Decision Making by Rodents
07:05

Operant Protocols for Assessing the Cost-benefit Analysis During Reinforced Decision Making by Rodents

Published on: September 10, 2018

6.4K
Practical Methodology of Cognitive Tasks Within a Navigational Assessment
05:19

Practical Methodology of Cognitive Tasks Within a Navigational Assessment

Published on: June 1, 2015

14.0K
Assessing Dyslexia at Six Year of Age
15:00

Assessing Dyslexia at Six Year of Age

Published on: May 1, 2020

8.7K

Area of Science:

  • Biotechnology
  • Immunology
  • Drug Discovery

Background:

  • Therapeutic antibody generation is a lengthy and costly process.
  • Current methods face challenges in speed and cost-efficiency.
  • Advancements in technology are needed to streamline antibody development.

Purpose of the Study:

  • To highlight the necessity of integrating in silico predictions with advanced screening and characterization technologies.
  • To demonstrate how combining computational and experimental approaches can accelerate therapeutic antibody generation.
  • To illustrate the simultaneous application of these technologies in antibody development.

Main Methods:

  • Utilizing in silico prediction tools for antibody design and optimization.
  • Employing cutting-edge high-throughput screening technologies.
  • Implementing advanced biophysical and functional characterization techniques.
  • Integrating computational and experimental data for iterative development.

Main Results:

  • Demonstrated acceleration in identifying promising antibody candidates.
  • Showcased reduction in overall development timelines and costs.
  • Provided examples of successful integration of diverse technological platforms.
  • Validated the efficacy of combined approaches through case studies.

Conclusions:

  • The integration of in silico predictions with advanced screening and characterization is crucial for faster and more cost-effective therapeutic antibody generation.
  • Simultaneous application of these technologies represents the future of antibody development.
  • This integrated approach significantly enhances the efficiency of bringing novel antibody therapeutics to market.